Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 17.78
-0.24 (-1.33%)
Sep 11, 2026, 3:00 PM CST
SHA:600645 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,284 | 1,010 | 1,528 | 1,581 | 1,393 | 1,196 |
Trading Asset Securities | 533.32 | 712.05 | - | - | - | - |
Cash & Short-Term Investments | 1,818 | 1,722 | 1,528 | 1,581 | 1,393 | 1,196 |
Cash Growth | 13.47% | 12.72% | -3.38% | 13.48% | 16.54% | 12.76% |
Accounts Receivable | 577.98 | 628.36 | 644.94 | 610.53 | 575.98 | 510.95 |
Other Receivables | 14.07 | 3.27 | 1.99 | 18.09 | 28.41 | 16.58 |
Receivables | 592.04 | 631.63 | 646.93 | 628.62 | 604.39 | 527.53 |
Inventory | 236.02 | 230.23 | 232.19 | 247.9 | 248.09 | 226.96 |
Prepaid Expenses | - | 0 | 0.51 | 2.38 | 6.48 | 2.98 |
Other Current Assets | 78.99 | 72.92 | 48.89 | 48.36 | 57.64 | 77.08 |
Total Current Assets | 2,725 | 2,657 | 2,456 | 2,508 | 2,310 | 2,030 |
Property, Plant & Equipment | 583.25 | 613.97 | 688.71 | 705.33 | 765.54 | 766.09 |
Long-Term Investments | 719.76 | 732.72 | 736.84 | 779.96 | 804.31 | 886.53 |
Goodwill | 702.91 | 702.91 | 702.91 | 702.91 | 702.91 | 702.91 |
Other Intangible Assets | 115.23 | 84.7 | 100.45 | 101.42 | 111.73 | 133.96 |
Long-Term Accounts Receivable | - | 19.28 | 28.47 | 37.45 | 52 | 65.9 |
Long-Term Deferred Tax Assets | 49.91 | 50.46 | 92.95 | 81.8 | 56.02 | 46.94 |
Long-Term Deferred Charges | 115.06 | 166.6 | 165.22 | 159.98 | 148.88 | 141.13 |
Other Long-Term Assets | 275.68 | 264.68 | 277.08 | 334 | 333.2 | 259.72 |
Total Assets | 5,287 | 5,292 | 5,249 | 5,411 | 5,285 | 5,033 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 104.03 | 38.55 | 47.32 | 68.76 | 56.85 | 32.12 |
Accrued Expenses | 48.88 | 166.56 | 170.15 | 146.96 | 134.91 | 132.33 |
Current Portion of Long-Term Debt | 26.46 | - | - | 6.31 | 6.31 | 6.31 |
Current Portion of Leases | - | 21.39 | 43.75 | 23.34 | 21.19 | 16.69 |
Current Income Taxes Payable | 27.34 | 10.54 | 6.71 | 17.93 | 30.38 | 24.97 |
Current Unearned Revenue | 1,123 | 1,133 | 1,134 | 1,137 | 1,112 | 1,078 |
Other Current Liabilities | 101.16 | 87.96 | 85.4 | 81.29 | 109.64 | 105.56 |
Total Current Liabilities | 1,430 | 1,458 | 1,487 | 1,482 | 1,471 | 1,396 |
Long-Term Debt | - | - | - | 9.46 | 15.77 | 22.08 |
Long-Term Leases | 42.21 | 58.88 | 80 | 88.37 | 97.9 | 37.11 |
Long-Term Unearned Revenue | 10.28 | 10.08 | 9.56 | 10.02 | 10.92 | 11.08 |
Long-Term Deferred Tax Liabilities | 9.5 | 10.55 | 12.95 | 23.15 | 34.87 | 34.7 |
Other Long-Term Liabilities | 11.6 | - | - | - | - | - |
Total Liabilities | 1,504 | 1,537 | 1,590 | 1,613 | 1,631 | 1,501 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 467.95 | 467.95 | 467.95 | 467.95 | 467.95 | 467.95 |
Additional Paid-In Capital | 3,389 | 3,389 | 3,374 | 3,377 | 3,384 | 3,383 |
Retained Earnings | -19.04 | -80.09 | -193.92 | -294.27 | -400.73 | -513.71 |
Treasury Stock | -200.03 | -200.03 | -200.03 | - | - | - |
Comprehensive Income & Other | 101.34 | 129.8 | 147.54 | 133.31 | 104.7 | 125.98 |
Total Common Equity | 3,740 | 3,707 | 3,595 | 3,684 | 3,556 | 3,463 |
Minority Interest | 43.07 | 48.24 | 63.98 | 114.55 | 97.85 | 69.31 |
Shareholders' Equity | 3,783 | 3,755 | 3,659 | 3,799 | 3,654 | 3,533 |
Total Liabilities & Equity | 5,287 | 5,292 | 5,249 | 5,411 | 5,285 | 5,033 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 68.68 | 80.27 | 123.75 | 127.48 | 141.18 | 82.2 |
Net Cash (Debt) | 1,749 | 1,642 | 1,404 | 1,454 | 1,252 | 1,113 |
Net Cash Growth | 15.86% | 16.94% | -3.42% | 16.09% | 12.46% | 11.14% |
Net Cash Per Share | 3.74 | 3.61 | 3.08 | 3.14 | 2.66 | 2.37 |
Filing Date Shares Outstanding | 454.31 | 455.9 | 455.9 | 467.95 | 467.95 | 467.95 |
Total Common Shares Outstanding | 454.31 | 455.9 | 455.9 | 467.95 | 467.95 | 467.95 |
Working Capital | 1,294 | 1,199 | 968.93 | 1,027 | 838.53 | 634.56 |
Book Value Per Share | 8.23 | 8.13 | 7.89 | 7.87 | 7.60 | 7.40 |
Tangible Book Value | 2,921 | 2,919 | 2,792 | 2,880 | 2,741 | 2,627 |
Tangible Book Value Per Share | 6.43 | 6.40 | 6.12 | 6.15 | 5.86 | 5.61 |
Land | - | 3.46 | 3.54 | 3.49 | 3.43 | 3.14 |
Buildings | - | 546.03 | 546.68 | 482.6 | 497.7 | 558.38 |
Machinery | - | 696.34 | 700.82 | 690.88 | 653.02 | 623.86 |
Construction In Progress | - | 5.65 | 10.54 | 18.98 | 23.23 | 20.5 |